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Amniona b s t r a c t
Limbal epithelial stemcell (LESC) deﬁciency can cause blindness. Transplantation of cultured human limbal
epithelial cells (hLE) onhumanamnioticmembrane (HAM) can restore visionbut clinical graftmanufacture
can be unreliable. We have developed a reliable and robust tissue equivalent (TE) alternative to HAM, Real
Architecture for 3D Tissue (RAFT). Here, we aimed to optimize the optical and mechanical properties of
RAFT TE for treatment of LESC deﬁciency in clinical application. The RAFT TE protocol is tunable; varying
collagen concentration and volume produces differing RAFT TEs. These were comparedwith HAM samples
taken from locations proximal anddistal to theplacental disc. Outcomes assessedwere transparency, thick-
ness, light transmission, tensile strength, ease of handling, degradation rates and suitability as substrate for
hLE culture. Proximal HAM samples were thicker and stronger with poorer optical properties than distal
HAM samples. RAFT TEs produced using higher amounts of collagenwere thicker and stronger with poorer
optical properties than those produced using lower amounts of collagen. The ‘optimal’ RAFT TE was thin,
transparent but still handleable and was produced using 0.6 ml of 3 mg/ml collagen. Degradation rates of
the ‘optimal’ RAFT TE andHAMwere similar. hLE achieved conﬂuency on ‘optimal’ RAFT TEs at comparable
rates to HAM and cells expressed high levels of putative stem cell marker p63a. These ﬁndings support the
use of RAFT TE for hLE transplantation towards treatment of LESC deﬁciency.
 2015 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction repopulated by the progeny of limbal epithelial stem cells (LESC)The cornea is the uniquely transparent tissue located on the
front of the eyeball that provides us with a window to the world.
It is multilayered, consisting of an epithelium, Bowman’s layer,
stroma, Descemet’s membrane and endothelium [1]. The stroma
accounts for the majority of the thickness of the cornea but
remains optically transparent due its highly organized structure,
comprising optimally spaced, orthogonally arranged lamellae of
collagen ﬁbrils. This arrangement is tightly controlled to ensure
that the stroma remains transparent throughout life, so that visual
acuity is maintained, which is the major functional requirement of
corneal tissue [2].
A continuously renewed epithelial cell layer protects the under-
lying stroma from external damage. Sloughed epithelial cells arethat are located in the limbus, the vascularized border between
central cornea and conjunctiva [3,4]. However, if LESC are damaged
or lost, this can no longer occur. Inﬂammation, vascularization and
ingrowth of neighbouring conjunctival cells follow and can lead to
loss of corneal transparency [5].
One treatment for LESC deﬁciency is transplantation of pre
expanded human limbal epithelial cells (hLE) on a carrier, such
as human amniotic membrane (HAM) [6–8]. Although often effec-
tive, clinical graft manufacture using HAM can be inconsistent, per-
haps due to its inherent biological variability [8–10]. Additionally,
intra donor variation also exists whereby HAM samples isolated
from different locations display different physical properties
[11,12]. Further drawbacks of HAM are that before use, it must
be screened, which is costly, and supply can also be unreliable [13].
As a result, many have aimed to develop materials that could be
used for transplantation of hLE in place of HAM. Criteria for such a
material should include capability to support hLE expansion along
with appropriate optical and mechanical properties (i.e. the mate-
rial should be as transparent as possible, but also be strong enough
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materials range from naturally occurring materials such as ﬁbrin,
[14,15], ﬁsh scale collagen [16] and silk ﬁbroin [17,18] to engi-
neered polymers such as poly(lactide co glycolide) [19] and poly
e caprolactone [20].
Our approach is a tissue equivalent (TE), RAFT (Real
Architecture for 3D Tissue), produced by gently wicking water
away from Type 1 collagen hydrogels using hydrophilic porous
absorbers [21]. Collagen is an attractive material for regenerative
medicine applications as it is biocompatible, lowly immunogenic,
can be remodelled by cells and is already used in numerous clinical
applications (reviewed in [22]). We have previously shown that
RAFT TEs can support hLE expansion and established RAFT TE as
a good in vitro model of central cornea [23] and limbus [21]. The
RAFT TE production process has also been through numerous iter-
ations such that it is now reliable, robust and reproducible
[21,23,24], which is desirable when developing tissue engineered
products.
However, although promising in terms of biological function,
we had not yet optimized RAFT TEs in terms of physical properties.
Therefore, the aim of this study was to optimize the RAFT TE pro-
duction process, which fortunately is tunable, to produce TEs with
appropriate optical and mechanical properties for use in the treat-
ment of LESC deﬁciency. RAFT TEs were compared to denuded
HAM, which is a commonly used carrier for cultured hLE
transplantation.2. Materials and methods
2.1. Chemicals
All chemicals were obtained from Life Technologies, Paisley, UK,
unless stated otherwise.
2.2. Preparation of RAFT constructs
Bovine dermis Type I collagen (Koken, Tokyo, Japan) (8 parts)
was mixed with 1 part 10x Minimum Essential Medium (MEM)
(Invitrogen). Collagen was used either neat (3 mg/ml) or prediluted
using 1 mM hydrochloric acid (HCl) to 2 mg/ml or 1 mg/ml.
Sodium hydroxide (5 M) was added dropwise to neutralize the
solution to achieve a pH between 7.2 and 7.4. Finally, 1 part 1x
MEM was mixed in carefully. This mixture was left on ice for
30 min to allow any air bubbles to disperse. The neutralized colla-
gen mixture was pipetted into individual wells of a 24 well plate
(Greiner, Stonehouse, UK) in volumes of either 2.4 ml, 1.2 ml or
0.6 ml, and heated to 37 C for 30 min so that ﬁbrillogenesis
occurred, and a hydrogel formed. The majority of the liquid was
wicked away from the hydrogels to produce RAFT TEs by applica-
tion of hydrophilic porous absorbers (TAP Biosystems, Royston,
UK) to the surface of the hydrogels for 30 min at 37 C as described
previously [21]. RAFT TEs were stored at 4 C in phosphate buffered
saline (PBS) before analysis. (For clarity, the protocol for RAFT TE
production in previous studies was 2.4 ml of 2 mg/ml collagen
[21,23]).
2.3. Preparation of human amniotic membrane samples
HAM samples with appropriate research consent were obtained
from the University Eye Hospital (Heinrich Heine Universität,
Düsseldorf, Germany). Ethical permission for this study was
obtained from the Research Ethics Committee (UK) (reference No.
10/H0106/57-11ETR10). HAM samples from areas proximal and
distal to the placental disc were isolated from 3 donors. In a lami-
nar ﬂow hood, intact HAM was washed with PBS to remove blood,before being stripped from the chorion. HAM was stored at 80 C
in 1x antibiotic, antimycotic/Dulbecco’s Modiﬁed Eagle Medium
(100 IU/ml penicillin, 100 lg/ml streptomycin, 0.25 lg/ml fungi-
zone). Prior to use, HAM was defrosted in a 37 C water bath and
washed for 3  10 min in Hank’s Balanced Salt Solution, once with
agitation. HAM was oriented epithelial side up, and incubated with
0.25% trypsin ethylenediaminetetraacetic acid for 10 min and
epithelium removed using cell scrapers. Denuded HAM was tre-
phined using a 16 mm trephine (AngioTech, Vancouver, Canada)
and stored in PBS in 24 well plates at 4 C until analysis.
2.4. Subjective assessment of transparency
HAM and RAFT TE samples were placed over text (font:
Cambria, size: 12), whilst still in a 24 well plate, still with 1 ml
of PBS on top. Macroscopic photos were taken from a ﬁxed distance
using the same level of diffuse illumination.
2.5. Thickness measurements
The thickness of each RAFT TE and HAM sample was measured
using optical coherence tomography (OCT). The PBS was aspirated
and samples held in place between 2 glass coverslips. An OCT
machine with anterior segment adaptor (HRA and OCT Spectralis,
Heidelberg Engineering, Hemel Hempstead, UK) was used to image
individual samples (10 line scans per sample). Images were opened
using ImageJ software and scale calibrated. The line measurement
tool was used to measure the thickness of the samples (all 10 scans
per image were used for these measurements). OCT measurements
were performed in triplicate for RAFT TEs and in duplicate for HAM
samples within each experiment.
2.6. Transparency measurements
The PBS was aspirated from all samples and 14 masked obser-
vers assessed the transparency of each RAFT TE and HAM sample
on 3 different days from a ﬁxed distance using a standardized
chart. Visual acuity of each masked observer was 20/20 or better
with glasses or contact lens correction worn where required. An
empty well of a 24 well plate was used as a control. The last line
successfully read by each masked observer through control and
test wells was recorded. When transparency of the sample was
too poor to permit line 1 to be read, this was scored as 0 lines.
2.7. Light transmission measurements
Absorbance (400–700 nm) of RAFT TE and HAM samples with
1 ml of PBS on top was measured using a spectrophotometer
(SAFIRE, Tecan, Reading, UK). A well containing 1 ml of PBS alone
was used as a control. Absorbance readings were converted to per-
centage transmission using: % transmission = 10–absorbance  100
[25]. Absorbance readings were performed in duplicate for each
RAFT TE or HAM sample within each experiment.
2.8. Mechanical property testing
2.8.1. Quantitative
RAFT TE and HAM samples were removed from PBS storage and
cut into ‘‘dog bone’’ shapes as described previously [26], 4 mm
wide and 10 mm long, using a scalpel. Each end of the samples
was clamped between metal mesh grips (MeshDirect, Burslem,
UK) and loaded into a custom made tensile strength testing device,
similar to that described previously [26]. Samples were held in
place and weights applied incrementally until failure (breakage).
The load at which failure occurred was recorded (any samples that
slipped, instead of breaking, were excluded from analysis). Break
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force/cross sectional area [27]. (Cross sectional area was calculated
using OCT thickness measurements.) This was performed in tripli-
cate for each RAFT TE and HAM sample.
2.8.2. Qualitative
Porcine eyes (FirstLink, Wolverhampton, UK) were transported
to the laboratory on ice within 24 h post mortem. Excess skin, mus-
cle and conjunctival tissue was removed. Eyes were disinfected by
immersion into 2% povidone solution for 2 min, before a 1 min
wash in 1x antibiotic, antimycotic in PBS. RAFT TEs (produced
using 0.6 ml of 3 mg/ml collagen, 2.4 ml of 2 mg/ml collagen, and
2.4 ml of 3 mg/ml collagen) were transferred to the anterior sur-
face of the eyes using forceps and glued in place using a ﬁbrin glue,
TISSEEL Lyo (Baxter, Norfolk, UK). Macroscopic photos were taken
to demonstrate successful attachment and RAFT TEs were physi-
cally dragged to ensure attachment was secure.
2.9. Degradation study
HAM samples from 3 donors, and RAFT TEs produced using
0.6 ml of 3 mg/ml collagen were incubated in 1 ml of collagenase
solution in DMEM (at either 10 mg/ml, 5 mg/ml or 1 mg/ml) at
37 C for 24 h. As a control, samples were also incubated in
DMEM alone (without collagenase). 100 ll aliquots of the solution
were removed from each sample after 15, 30, 60, 240 and
1440 min. Photographs were taken at the same intervals.
Collagen concentration in the solution was measured using the
Total Collagen Assay (QuickZyme Biosciences, Leiden, Holland)
according to the manufacturer’s instructions. All samples were
diluted 1 in 10 in 4 M HCl before analysis, apart from those taken
at 15 min, which were diluted 1 in 5, whilst blank and control sam-
ples were not diluted.
Results are expressed as percentage degradation compared to
24 h incubation in the same concentration of collagenase, calcu-
lated using the following formula:
ðcollagen concentration at t15; 30; 60 or 240=collagen concentration at t1440Þ
100:
These experiments were performed in triplicate for each RAFT TE
and HAM sample.
2.10. Preparation of human amniotic membrane for human limbal
epithelial cell culture
Denuded HAM biopsies were cut into squares measuring
30 mm  30 mm. The HAM was orientated so that the stroma
was facing upwards. A sterile coverslip was placed on top and
the free edges of the HAM biopsy folded around the coverslip. A
second sterile coverslip was placed on top to secure the HAM in
place. Mesh was removed from cell culture inserts (Millipore,
Watford, UK) using a scalpel and the HAM biopsies placed on
top. The top coverslip was then removed and edges of the HAM
biopsy folded down around the cell culture insert. The ﬁnal cover-
slip was carefully removed and the HAM secured in position using
a suture. The cell culture insert was then orientated the correct
way up (so that the stromal side of the HAM faced downwards).
2.11. Human limbal epithelial cell isolation and culture
6 cadaveric donor corneal rims with appropriate research con-
sent were obtained from Moorﬁelds Lions Eye Bank (UK). Ethical
permission for this study was obtained from the Research Ethics
Committee (UK) (Reference number 10/H0106/57-11ETR10).Corneas were stored at 31 C in organ culture medium after enu-
cleation and prior to hLE culture.
Aspreviously [28], corneal rimswerewashed in1xantibiotic/PBS
(3  10 min). The superﬁcial limbus was dissected away from the
stroma and cut into 2 mm segments using ﬁne sprung scissors and
incubated overnight at 37 C in a 5% CO2 in air incubator in 10 ml
of 0.5 mg/ml collagenase type-L (Sigma–Aldrich, Dorset, UK). The
next day, cells and tissues were pipetted up and down using a
10 ml pipette. The resulting cell suspension was centrifuged at
1000g for 5 min, and pellet washed using 3 ml of PBS. A second cen-
trifugation was performed before the cell pellet was resuspended in
culture medium (DMEM:MCDB-201 (3:2, Sigma–Aldrich), 2% foetal
bovine serum, penicillin (100 IU/ml), streptomycin (100 lg/ml),
gentamycin (50 lg/ml), AlbuMAX-I (1 mg/ml), L-ascorbic
acid-2-phosphate sesquimagnesium salt (0.12 mM, Sigma–
Aldrich), insulin transferrin selenium solution (1x), dexamethasone
(10nM, Sigma–Aldrich), cholera toxin (100 ng/ml, Sigma–Aldrich),
platelet-derived growth factor (10 ng/ml, R&D Systems, Abingdon,
UK) and epidermal growth factor (10 ng/ml, Sigma–Aldrich)). The
resulting cell suspension from each donor cadaveric rim was split
either between 2 RAFT TEs (produced using 0.6 ml of 3 mg/ml colla-
gen) and 2 HAM biopsies (N = 3), or split between 4 RAFT TEs (pro-
duced using 0.6 ml of 3 mg/ml collagen) (N = 3). Culture medium
was changed 3 times per week and cells were maintained at 37 C
in a 5% CO2 in air incubator until conﬂuency.
2.12. Wholemount immunohistochemistry
At conﬂuency, RAFT TEs and HAM biopsies were ﬁxed in 4%
paraformaldehyde (PFA) (VWR, Leicestershire, UK) for 30 min,
washed in PBS (3  5 min). Samples were blocked in 5% normal
goat serum with 0.25% Triton X in PBS for 1 h. A capture antibody
against putative stem cell marker p63a (Cell Signaling Technology,
Herts, UK) was applied at 1:50 in 2% goat serum in PBS overnight at
4 C. Isotype negative controls (Santa Cruz, Dallas, US) were
included.
The next day, samples were washed in PBS (3  5 min). A sec-
ondary goat anti-rabbit 594 Alexa Fluor antibody was applied at
1:500 in PBS simultaneously with ﬂuorescein isothiocyanate–phal
loidin at 1:1000, to visualize cellular architecture, for 1 h at room
temperature in the dark. Samples were washed in PBS (3  5 min)
andmountedwith 40,6-diamidino-2-phenylindole (DAPI)mounting
medium (Vector Labs, Peterborough, UK), onto glass slides. Confocal
analysis was performed using a Zeiss LSM 710 microscope (Zeiss,
Cambridge, UK).
2.13. Statistics
Results are expressed as average of 3 experimental
repeats ± standard deviation, unless stated otherwise. GraphPad
Prism software was used for statistical analyses. Signiﬁcant differ-
ences between groups were tested using student’s t-test (2 groups)
or one-way ANOVAs (more than 2 groups). For transmission,
degradation, statistical analyses were performed after arcsine
transformation [29]. Multiple linear regression analysis was used
to determine correlation. For all statistical tests, p < 0.05 was con-
sidered statistically signiﬁcant.3. Results
3.1. Subjective assessment of transparency reveals that collagen
concentration and volume affects RAFT TE appearance
Macroscopic photographs taken over text through either RAFT
TEs or HAM samples revealed obvious differences in both RAFT
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all of the RAFT TEs but transparency appeared greatest for RAFT TEs
made using 0.6 ml of 1 mg/ml collagen, whilst RAFT TEs made
using 2.4 ml of 3 mg/ml collagen appeared least transparent.
Subjective transparency was good for all 3 HAM donors and similar
to RAFT TEs produced using 0.6 ml volumes of all 3 concentrations
of collagen.Fig. 2. Thickness of RAFT TEs and HAM samples. RAFT TE and HAM sample
thickness was measured using OCT. RAFT TEs were produced using either 0.6 ml,
1.2 ml or 2.4 ml of 1 mg/ml collagen (black bars), 2 mg/ml collagen (light grey bars)
or 3 mg/ml collagen (mid grey bars) and compared with proximal (white bar) and
distal (checkerboard bar) HAM samples. Data are averages from 3 experimental
repeats ±SD. ⁄p < 0.05 compared to RAFT TEs produced using the same volume of
collagen but 1 mg/ml collagen. §p < 0.05 compared to RAFT TEs produced using the
same concentration of collagen but 0.6 ml volume. d p < 0.05 compared to distal
HAM samples. p p < 0.05 compared to proximal HAM samples.3.2. RAFT TE thickness is affected by both collagen volume and
concentration, and is similar to that of HAM
RAFT TE thickness varied when different concentrations and
volumes of collagen were used (Fig. 2). The thinnest RAFT TEs were
produced using 0.6 ml of 1 mg/ml collagen (52.5 ± 8.9 lm), whilst
the thickest RAFT TEs were produced using 2.4 ml of 3 mg/ml col-
lagen (410.9 ± 4.2 lm). For all 3 volumes of collagen used, RAFT TEs
produced using 3 mg/ml collagen were thicker than those pro-
duced using 1 mg/ml collagen (p < 0.05). Similarly, for all 3 concen-
trations of collagen used, RAFT TEs produced using 2.4 ml of
collagen were thicker than those produced using 0.6 ml of collagen
(p < 0.05). Linear regression analysis revealed a positive correlation
between collagen volume and RAFT TE thickness (R2 = 0.5333,
p < 0.05).
All proximal HAM samples were thicker than distal HAM sam-
ples isolated from the same donor (n.s. p > 0.05). RAFT TEs pro-
duced using 0.6 ml of 1 mg/ml collagen were thinner than both
proximal and distal HAM samples (p < 0.05), whereas RAFT TEs
produced using 2.4 ml of 3 mg/ml collagen were thicker than both
proximal and distal HAM samples (p < 0.05). All other RAFT TEs
were of comparable thicknesses to HAM samples (p > 0.05).Fig. 1. Subjective assessment of RAFT TE and HAM transparency. RAFT TEs were
produced using different collagen volumes (0.6 ml, 1.2 ml or 2.4 ml) and concen-
trations (1 mg/ml, 2 mg/ml, or 3 mg/ml) and compared to proximal and distal HAM
samples isolated from 3 donors. Macroscopic images of text through either RAFT
TEs (A) or HAM (B) were captured for qualitative comparison.3.3. Transparency of RAFT TEs is affected by both collagen volume and
concentration, and is similar to that of HAM
Transparency was greater for the control well than for any of
the RAFT TE or HAM samples (p < 0.005) (Fig. 3). Transparency of
RAFT TEs was affected by both collagen concentration and volume.
For RAFT TEs produced using 1.2 and 2.4 ml of collagen, RAFT TEs
produced using 1 mg/ml collagen were more transparent than
those produced using 3 mg/ml collagen (p < 0.005). When 2.4 ml
of collagen was used, this improvement in transparency was also
apparent between RAFT TEs produced using 1 and 2 mg/ml colla-
gen (p < 0.01). This effect was not apparent for RAFT TEs produced
using 0.6 ml of collagen.
For all 3 concentrations of collagen, RAFT TEs produced using
0.6 ml of collagen were more transparent than those produced
using both 1.2 ml of collagen (p < 0.05) and 2.4 ml of collagen
(p < 0.005). For RAFT TEs produced using 2 and 3 mg/ml collagen,
these differences were also apparent between 1.2 ml of collagen
and 2.4 ml of collagen (p < 0.05). Linear regression analysis
revealed a negative correlation between transparency and collagen
volume (R2 = 0.6971, p < 0.01) and RAFT TE thickness (R2 = 0.5565,
p < 0.05).
For donors 1 and 2, distal HAM was more transparent than
proximal HAM (p < 0.01). RAFT TEs produced using 0.6 ml of
1 mg/ml collagen were more transparent than proximal HAM sam-
ples (p < 0.01). However, RAFT TEs produced using 2.4 ml of
2 mg/ml collagen or 3 mg/ml were less transparent than both
proximal (p < 0.01) and distal (p < 0.05) HAM samples. Similarly,
RAFT TEs produced using 1.2 ml of 3 mg/ml collagen were less
transparent than distal HAM samples (p < 0.05). All other RAFT
TEs were comparable to HAM samples (p > 0.05).3.4. Light transmission through RAFT TEs is affected by both collagen
concentration and volume, and transmission values approach those of
HAM
For both RAFT TEs and HAM samples, transmission increased
with wavelength between 400 and 700 nm (Fig. 4A).
Fig. 3. Transparency of RAFT TEs and HAM samples. A: standardized chart used in this study (left) with line numbers (right) indicated. B: RAFT TEs were produced using
either 0.6 ml, 1.2 ml or 2.4 ml of 1 mg/ml collagen (black boxes), 2 mg/ml collagen (light grey boxes) or 3 mg/ml collagen (mid grey boxes). Masked observers assessed
transparency of the different RAFT TEs, HAM samples (far right), and control well (far left). Data are averages from 14 masked observers: central line represents median, box
represents ﬁrst and third quartiles, and whiskers represent minimum and maximum. ^^^p < 0.005 compared to all RAFT TE and HAM samples. §p < 0.05, §§§p < 0.005
compared to RAFT TEs produced using the same concentration of collagen but 0.6 ml volume. p < 0.05 compared to RAFT TEs produced using the same concentration of
collagen but 1.2 ml volume. ⁄⁄p < 0.01, ⁄⁄⁄p < 0.005 compared to RAFT TEs produced using the same volume of collagen but 1 mg/ml collagen. %%p < 0.01 compared to
proximal HAM samples isolated from the same donor. d p < 0.05 distal HAM samples compared to RAFT TE. pp p < 0.01 proximal HAM samples compared to RAFT TE.
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by both collagen concentration and volume (Fig. 4B). RAFT TEs pro-
duced using 0.6 ml of 1 mg/ml collagen permitted most light trans-
mission (81.1 ± 6.5%), whilst those produced using 2.4 ml of
3 mg/ml permitted the least (13.2 ± 4.7%). For RAFT TEs produced
using 1.2 ml and 2.4 ml of collagen, 1 mg/ml collagen RAFT TEs
transmitted more light than those produced using 3 mg/ml colla-
gen (p < 0.05). For all 3 concentrations of collagen, RAFT TEs pro-
duced using 0.6 ml of collagen permitted greater transmission
than those produced using 2.4 ml of collagen (p < 0.05). Linear
regression analysis revealed a negative correlation between light
transmittance and collagen volume (R2 = 0.7955, p < 0.005) and
RAFT TE thickness (R2 = 0.7786, p < 0.005).
For each donor, distal HAM samples permitted greater light
transmission than proximal HAM samples, but these differences
were not statistically signiﬁcant. Both proximal and distal HAM
biopsies were more transmissive than RAFT TEs produced using
2.4 ml of 2 mg/ml collagen (p < 0.05) and 3 mg/ml collagen
(p < 0.01). All other RAFT TEs were comparable to HAM samples
(p > 0.05).
3.5. RAFT TE mechanical properties are affected by both collagen
volume and concentration, and is similar to that of HAM
The average break force for RAFT TEs was affected by both col-
lagen volume and concentration (Table 1). RAFT TEs produced
using 0.6 ml of 2 mg/ml collagen broke under the smallest applied
force (0.105 ± 0.023 N), whilst those produced using 2.4 ml of
3 mg/ml collagen broke under the greatest applied force
(0.732 ± 0.098 N). Linear regression analysis revealed a positive
correlation between break force and collagen volume
(R2 = 0.5983, p < 0.05). (RAFT TEs produced using 0.6 ml of 1 mg/ml
collagen were too weak to be tested accurately and so results for
these are not presented.)
The tensile strength of RAFT TEs produced using 1.2 ml of colla-
gen was affected by collagen concentration (Fig. 5A): RAFT TEs pro-
duced using 3 mg/ml collagen failed under greater stress thanthose produced using 1 mg/ml collagen (p < 0.05). RAFT TEs
produced using 0.6 ml of 2 mg/ml collagen broke under the
smallest stress (0.35 ± 0.08 MPa), whilst those produced
using 2.4 ml of 2 mg/ml collagen broke under the greatest stress
(0.70 ± 0.13 MPa).
For each of the 3 HAM donors, proximal HAM samples broke
under a greater applied force and stress than distal HAM samples,
although neither difference was statistically signiﬁcant. RAFT TEs
produced using 0.6 ml of 2 mg/ml collagen, 1.2 ml of 1 mg/ml
collagen and 2.4 ml of 3 mg/ml collagen all failed at a lower break
stress than proximal HAM samples (p < 0.05). All other RAFT TEs
were comparable to both proximal distal HAM samples (p > 0.05).3.6. RAFT TE with suitable optical properties for transplant can be
attached to the anterior surface of an ex vivo porcine eye
RAFT TEs produced using either 2.4 ml of 3 mg/ml, 2.4 ml of
2 mg/ml or 0.6 ml of 3 mg/ml collagen could all withstand manip-
ulation enabling attachment to the anterior surface of an ex vivo
porcine eye using ﬁbrin glue (Fig. 5B).3.7. RAFT TEs and HAM biopsies degrade over time in collagenase at
comparable rates
Both RAFT TEs and HAM samples degraded over time following
incubation with collagenase (Fig. 6). When collagenase was absent,
neither RAFT TEs not HAM samples degraded (collagen concentra-
tions in the solution remained unchanged between 0 and
1440 min, p > 0.05). Degradation was slowest in 1 mg/ml collage-
nase when for both RAFT TE and HAM samples: 50% degradation
occurred after approximately 60 min. Degradation was quicker in
5 mg/ml collagenase and 10 mg/ml collagenase, where approxi-
mately 50% degradation occurred after 30 min or less. Crucially,
at no time point, in any of the 3 concentrations of collagenase
tested, was there a difference in degradation rate between RAFT
TE and HAM samples (p > 0.05).
Fig. 4. Light transmission through RAFT TEs and HAM samples. A: transmission
(400–700 nm) through RAFT TEs produced using either 2.4 ml of 3 mg/ml collagen
(black circles), 2.4 ml of 2 mg/ml collagen (black squares) or 0.6 ml of 3 mg/ml
collagen (black triangles) was compared to transmission through proximal HAM
samples (grey circles) and distal HAM samples (grey squares). For clarity, this ﬁgure
shows data from a single, typical RAFT TE construct for each condition and one
typical HAM donor. B: transmission (550 nm) through RAFT TEs produced using
volumes of 0.6 ml, 1.2 ml or 2.4 ml of 1 mg/ml collagen (black bars), 2 mg/ml
collagen (light grey bars) or 3 mg/ml collagen (mid grey bars), and proximal (white
bar) and distal (checkerboard bar) HAM samples. Data are averages from 3
experimental repeats ±SD. ⁄p < 0.05 compared to RAFT TEs produced using the same
volume of collagen but 1 mg/ml collagen. §p < 0.05 compared to RAFT TEs produced
using the same concentration of collagen but 0.6 ml volume. d p < 0.05, dd p < 0.01
compared to distal HAM samples. p p < 0.05, pp p < 0.01 compared to proximal HAM
samples.
Table 1
Tensile strength testing of RAFT TEs and HAM samples.
Collagen concentration (mg/ml) Collagen v
RAFT TE 1 0.6
2
3
1 1.2
2
3
1 2.4
2
3
HAM donor number Sample loc
HAM 1 Proximal
Distal
2 Proximal
Distal
3 Proximal
Distal
246 I. Massie et al. / Acta Biomaterialia 24 (2015) 241–2503.8. Human limbal epithelial cells can be expanded on the surface of
optimal RAFT TEs, and transparency of RAFT TEs is maintained
hLE conﬂuency was achieved on all RAFT TEs (n = 6 donors) but
only on 2 out of 3 denuded HAM biopsies (n = 3 donors) (Fig. 7);
results from the unsuccessful HAM cultures have been excluded
from further analysis and so results are expressed as aver-
ages ± range. hLE took an average of 8.0 ± 3.0 days to reach conﬂu-
ency on RAFT TEs produced using 0.6 ml of 3 mg/ml collagen
(n = 6); this is comparable to hLE expansion on denuded HAM,
which took an average of 10.5 ± 0.5 days (n = 2). Wholemount
immunohistochemistry of hLE cultures on both RAFT TEs and
denuded HAM revealed that hLE were small, tightly packed, with
scant cytoplasm with cobblestone morphology. Cell densities and
p63a expression were also similar on each.
Importantly, transmission of light at 550 nm through RAFT TEs
was maintained once cell conﬂuency was achieved. Prior to cell
seeding, transmission at 550 nm was 68.23 ± 3.68%, which did
not differ from when hLE were conﬂuent across the surface of
RAFT TEs, 64.81 ± 5.70% (p > 0.05) (n = 4).4. Discussion
hLE transplantation is an established approach to treating LESC
deﬁciency (reviewed in [30,31]). However, the method of expand-
ing and carrying hLE to the patient is yet to be optimized. One of
the most commonly used carriers for LESC is HAM but clinical graft
manufacture can be inconsistent – optical and mechanical proper-
ties vary, expensive screening regimes are required, and supply can
be unreliable. As a result, we have developed RAFT TEs, which are
already proven to support hLE expansion and stratiﬁcation, sug-
gesting that they may be clinically useful [21,23]. hLE transplanta-
tion alone should contribute towards restoration of vision but the
carrier for hLE should also have appropriate optical properties so
that the beneﬁts of hLE transplantation are not counteracted. The
thickness of the TE is important as, if too thin, it may be too difﬁ-
cult to handle and lack the required mechanical strength.
Conversely, if too thick, it may project too far from the eyeball,
which may be uncomfortable for the recipient and complicate
the surgical procedure. In this study, we aimed to optimize the
physical properties of RAFT TEs. A potential caveat to our approach
is that we assume that batch-to-batch variation in our rawolume (ml) Average break force (Newtons) ± standard deviation
–
0.105 ± 0.023
0.167 ± 0.055
0.121 ± 0.049
0.216 ± 0.077
0.353 ± 0.014
0.261 ± 0.044
0.585 ± 0.109
0.732 ± 0.098
ation
0.544 ± 0.046
0.225 ± 0.055
0.490 ± 0.057
0.245 ± 0.085
0.408 ± 0.075
0.196 ± 0.049
Fig. 5. Mechanical properties of RAFT TEs and HAM samples. A: break stresses for
RAFT TEs and HAM samples were calculated following testing in a custom made
tensile strength testing device. RAFT TEs were produced using either 0.6 ml, 1.2 ml
or 2.4 ml of 1 mg/ml collagen (black bars), 2 mg/ml collagen (light grey bars) or
3 mg/ml collagen (mid grey bars) and compared with proximal (white bar) and
distal (checkerboard bar) HAM samples. (No data are presented for RAFT TEs
produced using 0.6 ml of 1 mg/ml collagen as these were too weak to be tested
accurately.) Data are averages from 3 experimental repeats ±SD. ⁄p < 0.05 compared
to RAFT TEs produced using the same volume of collagen but 1 mg/ml collagen. B:
RAFT TEs were produced using either 2.4 ml of 3 mg/ml collagen (1), 2.4 ml of
2 mg/ml collagen (2) or 0.6 ml of 3 mg/ml collagen (3) and glued onto the anterior
surface of an ex vivo porcine eye (4, without RAFT TE) using ﬁbrin glue.
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the collagen is tightly controlled by the suppliers’ own quality
management systems, and in our own experience we have found
that results are reproducible between different batches.
HAMwas utilized as a comparator with RAFT TEs as it is already
established in treatment of LESC deﬁciency. Both RAFT TEs and
HAM (biopsied from locations proximal and distal to placental
disc) were assessed using parameters designed to assess the feasi-
bility of RAFT TEs for hLE transplantation. Interestingly, despite the
relatively widespread use of HAM, surprisingly few studies have
characterized the HAM’s physical properties and reported ﬁndings
can be conﬂicting. Reported thicknesses of intact HAM samples
vary from 60 to 200 lm [11,32] (and measurements were taken
from images of from haematoxylin and eosin stained sections of
formalin ﬁxed, parafﬁn wax embedded samples [11], which will
have undergone dehydration/rehydration cycles). Similarly,
reported values for transmission of light through intact HAM sam-
ples vary between 50% and 80% at 550 nm [11,32].
In our study, we measured the thicknesses of the HAM samples
and RAFT TEs using OCT, without prior ﬁxation. It should be noted
that OCT assumes that materials will have similar refractive
indices. Human cornea and HAM are known to have similar refrac-
tive indices (1.33–1.37) [11,33] but the refractive index of RAFT TEs
is unknown. For this reason, we conﬁrmed our OCT measurements
using pachymetry and found no signiﬁcant difference in obtained
thickness values (data not shown), suggesting that the refractive
index of RAFT TE must be similar to cornea and HAM. In further
support of this, another similar collagenous TE intended for corneal
replacement has been found to have a refractive index of 1.35 [34].In agreement with others, we found intra donor variation in
HAM thicknesses [11]: proximal HAM samples tended to be thicker
than distal HAM samples. Despite this trend, we found that all of
the HAM samples from the 3 donors were of comparable thick-
nesses (100–150m). Similarly, we measured transmission at
550 nm to be 85–99% for all 3 donors, which again is more con-
sistent, but also higher, than previously reported. However, in our
study, we removed the epithelium from the HAM samples as
denuded HAM (i.e. without epithelium), would be utilized for
hLE expansion prior to transplant [35–38] and we wanted to com-
pare carriers directly (i.e. denuded HAM with RAFT TE (without
hLE)). This may account for the differences between our ﬁndings
and those previously reported, although it is acknowledged that
our sample size is relatively small.
Another important TE criterion is reproducibility. Since as many
HAMsamples as possible are harvested fromeach donor, thismeans
that any two samples harvested from the same donor may differ
fromeach other (conﬁrmedwhenwe compared samples taken from
locations proximal and distal to placental disc, differences were
most evident for mechanical properties). Along with the expected
inter donor variation, this intra donor variationmay further compli-
cate hLE expansion protocols and surgical procedures, and may
affect clinical outcome. In contrast, the process of RAFT TE produc-
tion is simpler as expensive screening regimes are not required, col-
lagen supply is more reliable, and a standardized product with
known physical properties can be achieved. This is useful in terms
of Good Manufacturing Practice protocol development and also
important as it simpliﬁes development of quality controls, potency
assays [39] and decisions regarding release criteria.
The RAFT TE production process is also tunable. By varying the
concentration and volume of collagen utilized to produce hydro-
gels, RAFT TEs with differing optical and mechanical properties
were achieved. In general, collagen concentration and volume
increased RAFT TE thickness and tensile strength, and decreased
light transmission and transparency. Overall, the total amount of
collagen impacted upon RAFT TE optical properties (i.e. RAFT TEs
produced using 2.4 ml of 1 mg/ml collagen or 1.2 ml of 2 mg/ml
collagen (both a total of 2.4 mg collagen) were comparable).
Encouragingly, the optical properties of the vast majority of RAFT
TEs produced using different amounts of collagen did not differ sig-
niﬁcantly from HAM samples, except when the very largest or
smallest amounts of collagen were used.
When we looked at the mechanical properties of RAFT TEs, we
found that the RAFT TEs produced using 2 smallest amounts of col-
lagen (excluding those produced using 0.6 ml of 1 mg/ml collagen,
which could not be handled) were signiﬁcantly weaker than
proximal HAM samples, but were still comparable to distal HAM
samples. Interestingly, RAFT TEs produced using 2.4 ml of 3 mg/ml
collagen withstood the greatest applied force of all RAFT TEs before
failure, but this equated to a lower break stress than anticipated, and
was instead similar to RAFT TEs produced using 1.2 ml of 2 mg/ml
collagen, a total of 3-fold less collagen. This may reﬂect that
dehydration of this hydrogel containing such a large amount of
collagen was incomplete after application of the hydrophilic
porous absorber. This hypothesis is supported by the fact that this
RAFT TEwas far thicker than any of the other RAFT TEs tested in this
study.
This capability to produce RAFT TEs with different properties is
useful and highlights that RAFT TEs may be useful in other regen-
erative medicine applications where different properties may be
prioritized. Here for ocular surface, we aimed to produce a thin,
transparent TE but where a stronger TE is required, for artiﬁcial
skin perhaps, a thicker, stronger, less transparent TE may be more
appropriate. In this study, we identiﬁed that RAFT TEs produced
using 0.6 ml of 3 mg/ml collagen provided the best optical proper-
ties but were still strong enough to be attached to an eye,
Fig. 6. Degradation of HAM and RAFT TE in the presence of collagenase. A: representative photographs of RAFT TEs and HAM samples after 0, 15, 30, 60, 240 and 1440 min
incubation with either 10 mg/ml, 5 mg/ml, 1 mg/ml or 0 mg/ml collagenase at 37 C. B, C, and D: Quantitative measurement of degradation of RAFT TE (closed markers) and
HAM samples (open markers) after incubation with 1 mg/ml collagenase (B), 5 mg/ml collagenase (C) or 10 mg/ml collagenase (D). Data are averages from 3 experimental
repeats ±SEM. There were no statistically signiﬁcant differences between % RAFT TE degradation and % HAM degradation at any time point using any concentration of
collagenase.
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treatment of LESC deﬁciency.
In order to conﬁrm the potential clinical applicability of these
‘optimal’ RAFT TEs, it was necessary to investigate their biodegrada-
tion over time. HAM is known to degrade following transplantation
[40]; this is useful since this can further improve visual acuity, as the
path of light through the cornea is not interrupted by the interface
between HAM and native stroma. Whilst it is difﬁcult to reproduce
the in vivo environment in vitro, matrix-metalloproteinases (includ-
ing collagenases) arepresent in corneas– indeedat elevated levels in
diseased or inﬂamed corneas [41] – which likely contribute to the
biodegradation of HAM over time. Importantly, we found that the
‘optimal’ RAFT TEs and HAM biopsies degraded at comparable rates
in vitro across a range of collagenase concentrations. Additionally,
the rate of RAFT TE degradation was much more uniform than for
HAM, where samples from different donors degraded at differing
rates when exposed to the same concentration of collagenase. That
biodegradation rates of RAFT TE are comparable with HAM is useful
as clinicians will be familiar with this. Additionally, that the rate of
RAFT TE degradation ismore uniformmay provide further clinicians
with further conﬁdence during follow-up after hLE transplantation.
We also sought to compare hLE cultures on ‘optimal’ RAFT TEs
with hLE cultures on HAM. We found that hLE expansion times
on either substrate did not differ, which is important given that
culture is expensive, time-consuming and delays patient treat-
ment. We also found that transparency of the RAFT TEs was unaf-
fected by the presence of a conﬂuent hLE layer, which is important
as this would negate producing a more transparent RAFT TE.
Crucially, we found that hLE morphology and p63a expression
was similar on RAFT TEs and HAM: hLE on both were tightly
packed and displayed a cobblestone morphology, with scantcytoplasm and high levels of putative stem cell marker p63a.
These characteristics are typical of undifferentiated cells: limbal
epithelial stem cells or their progeny, transient amplifying cells,
both of which contribute to corneal regeneration in vivo. On
RAFT TEs, expression of corneal epithelial differentiation markers,
such as cytokeratins 3/12, is typically only observed in superﬁcial
cell layers following culture at the air/liquid interface which trig-
gers spontaneous stratiﬁcation [23]. In this case, given that the
expression of p63a was so widespread, it seems likely that the
majority of the cells were in fact transient amplifying cells as
opposed to limbal epithelial stem cells. Since high levels of p63a
expression (i.e. a high number of undifferentiated cells) have pre-
viously been demonstrated to be important in in vitro potency
assays on RAFT TEs [39,42], these data further support that this
optimal RAFT TE would be a suitable substrate for hLE transplanta-
tion in the treatment of LESC deﬁciency.
One potential advantage of HAMover RAFT TE, that is not consid-
ered in this study, is that HAM is often reported to release soluble
factors that promote hLE proliferation and reduce neovasculariza-
tion post transplantation [43–46]. However, to treat LESC deﬁciency
effectively, hLE must be transplanted which requires in vitro pre
expansion either on HAM or RAFT TEs (this therapeutic approach
is more complex than alternative protocols where HAM is simply
used to patch epithelial defects and hLE transplantation is unneces-
sary [47]). It is possible that during hLE pre expansion the beneﬁcial
soluble factors from HAM are diluted out or even ‘‘swamped’’ by
those present in serum of culturemedium. Additionally, supporting
cells can be incorporated into RAFT TEs and it has been demon-
strated that these cells enhance hLE phenotype on RAFT TEs
in vitro [23], presumably via release of soluble factors.
Furthermore, once transplanted, hLE will be in close proximity to
Fig. 7. Characterization of hLE growth on HAM and RAFT TE. A: Time to conﬂuency was measured on both HAM and RAFT TE. Data are averages of 2 donors for HAM and 6
donors for RAFT TE ±range. B: % transmission at 550 nm through RAFT TE was measured before culture (no cells) and when a conﬂuent cell layer was present (at conﬂuence).
Data are averages of 4 donors ±SD, p > 0.05. C and D: wholemount immunohistochemistry was used to characterize hLE phenotype on both HAM (C) and RAFT TE (D). Images
are representative of 5 ﬁelds of view captured per RAFT TE (6 donors) or HAM biopsy (2 donors). Staining shows DAPI (blue), phalloidin (green) and putative stem cell marker
p63a (red). Scale bar = 50 lm.
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which, again, may improve clinical outcome.
5. Conclusions
LESC deﬁciency can cause blindness. Whilst hLE transplantation
is an established treatment for this disease, the method of delivery
is yet to be optimized. We have now demonstrated that the RAFT
TE production process is tunable, which is advantageous here as
optical and mechanical properties suitable for use on the front of
the eye can be made. RAFT TEs produced using 0.6 ml of 3 mg/ml
collagen were thin, and transparent but strong enough to with-
stand attachment to an eye. Moreover, these RAFT TEs degraded
at similar rates to HAM and were capable of supporting hLE cul-
tures in vitro, suggesting that this may be useful towards treatment
of LESC deﬁciency. However, the RAFT TE production process is
also tunable and may be easily altered in other regenerative med-
icine applications where other properties may be prioritized.
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